CLINICAL_TRIALS
trial_result
· 2018-03-19
Clinical Trial Update: Safety and Efficacy Study in Patients With Major Depressive Disorder [Phase 2]
Summary
Phase 2 safety and efficacy study in patients with major depressive disorder completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2018-03-19